Status:

RECRUITING

Cytokine Expression in Psoriasis Patients with and Without Joint Involvement

Lead Sponsor:

Poitiers University Hospital

Conditions:

Psoriasis

Psoriatic Arthritis

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The objective of the resarch is to study the cytokine profile of patients with psoriatic arthritis and psoriasis in order to better understand the pathophysiology of the disease and the contribution o...

Detailed Description

Psoriatic arthritis and Cutaneous Psoriasis are polygenic inflammatory disorders with high burden on the quality of life of patients. Pathophysiology of those disease remain incompletely understood. R...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • For psoriasis patients :
  • Age over 18 years old
  • Signed informed consent
  • 5 year old psoriasis at least
  • At least one skin lesion over 2 cm
  • Without any articular symptoms
  • Without any DMARDs
  • Without anticoagulant treatments or coagulation disease
  • With normal articular and enthesis sonography
  • For psoriatic arthritis patients :
  • Age over 18 years old
  • Signed informed consent
  • Psoriatic arthritis according to CASPAR criteria
  • Without any DMARDs
  • Without anticoagulant treatments or coagulation disease
  • With at least one synovitis at inclusion
  • For controls
  • Age and sex matched with a patient without any rheumatic or dermatologic medical conditions
  • No treatment with corticosteroïds or non-steroïdial anti-inflammatory drugsAge over 18 years old
  • Exclusion criteria:
  • ▪ For psoriasis patients :
  • Joint damage according to CASPAR criteria
  • Echography activity in favor of chronic inflammatory rheumatism
  • For patients and controls:
  • Without social protection rights
  • People under judiciary protection, of less than 18 years old, pregnant woman, breast feeding women, jailed patients.

Exclusion

    Key Trial Info

    Start Date :

    August 17 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 18 2026

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT05307809

    Start Date

    August 17 2022

    End Date

    August 18 2026

    Last Update

    September 4 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Chu Poitiers

    Poitiers, France